The Research and Development team at Promentis Pharmaceuticals is responsible for driving innovative research to discover and develop novel antipsychotic medications. This team collaborates closely across scientific disciplines to design and conduct preclinical and clinical trials, ensuring the safety and efficacy of new treatments for schizophrenia. Their efforts are pivotal in advancing therapeutic options and improving patient outcomes.
Chad E. Beyer
SVP of Research and Developmen...
Daniel C. Javitt
Scientific Advisor
Darin D. Dougherty
Scientific Advisor
David A. Baker
Scientific Advisor
Jon E. Grant
Scientific Advisor
Michael P. Neary
Director of Research
Patrick Schwarz-Schu...
Director
Peter W. Kalivas
Scientific Advisor
Robert Weisskoff
Director
Tim Keane
Director
View all